1Study on the construction of the quality evaluation system of Chinese drug GMP inspectionHU Shi-gao, WU Zhi-ang209-2152Key points on complement of continuous supply for national drug reference standardsGAO Zhi-feng, LUO Chen, LIU Ming-li, ZHAO Zong-ge, WANG Qing, SUN Hui-min216-2203Regulatory status and considerations on nitrosamine impurities in human drugsWANG Gong-fu, TANG Jia221-2284Regulatory practice and enlightenment of foreign drug frontier technologyYU Ming-li, XIA Wen-jing, JIANG Xiao-meng, WEN Bao-shu229-2405Research progress on the effect of glycosylation on vaccine immunogenicityWANG Her-ru, WU Ye-hong, HE Peng, HU Zhong-yu241-2466Research progress of long-acting growth hormone preparationsLIU Qing-yang, ZHANG Juan, HOU Zi-jing, KANG Chen, LIU Xin, ZHANG Bo, TANG Yan247-2547Clinical application advantages and prospects of innovative powder-liquid dual-chamber bagsLI He, BAI Qiu-ju, ZHANG Xiu-li, ZHANG Yu-jia, YANG Guo-hong, ZHENG Wen-sheng255-2608Prediction of the developing trend of decentralized clinical trials in China based on GM(1,1)modelZHANG Jing, JIA Zheng, FU Shu-yong, XING Hua261-2699Application of annotated case report form based on study data tabulation model in domestic clinical trialsTAN Lei, CHAO Jian-qian270-27310Investigation and analysis of the awareness degree of clinical trial liability insurance for investigator-initiated trialsCAO Ye, LIN Zhen, LI Bin-bin, LIU Ya-qing, FU Zhong274-27811Design,synthesis and activity evaluation of pyridinylcyclopropanecarboxamides targeting GSK-3β in brainsJIA Jian-hua, YANG Mei-xian, QIU Da-chuan279-28412Anti-tumor effect and the mechanism of a novel antibody targeting EGFR dimerLIANG Zhi-wen, ZHAO Lin, LI Ze-min, WANG Shuang, ZHU Lin-feng, WU Xue-man, CAI Jing-min, ZHENG Ke, LI Huang-jin285-29113Differential protein study between raw and processed products of Whitmania pigra Whitman using transcriptome and isobaric tags for relative and absolute quantitation proteomeHUA Yu-tong, LI Yin, GUO Xiu-huan, LEI Yan, XIN Quan-cheng, YUAN Rui-juan292-30014Determination of fluticasone propionate in raw materials and nasal sprays by UPLC-MS/MSCHEN Zhong-lan, ZHANG Ya-jun, SUN Hui-min, WANG Jin, WU Xian-fu301-30615Literature analysis of adverse drug reactions induced by nintedanibCHEN Zhe, QIN Yan, YE Yan-rong307-312 